Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue ...

Notably, the conference appears to have beefed up security around the main venue – the Westin St. Francis Hotel – this year in light of the killing of Brian Thompson, the CEO of UnitedHealth Group's ...

in New York City in December. Cluster of cops appear to be stationed in the area surrounding the hotel and metal barriers line the entrances of the venue, which are flanked by several private ...

FILE PHOTO: An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/File Photo · REUTERS / Reuters JPMorgan analyst ...

Stocks got a boost from a report showing inflation at the U.S. wholesale level wasn’t as high last month as economists expected.

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...